eSignal IPO Calendar

Week of Expected Pricing	Pending
Company Name	Amphastar pharmaceuticals Inc
Proposed Ticker	N/A
CUSIP	N/A
Business Description	A fully integrated specialty pharmaceutical company that develops, manufactures, markets, and sells generic and proprietary injectable and inhalation products.
Lead Underwriter	Lehman Brothers, UBS Investment Bank
Co-Managers	Deutsche Bank Securities
Initial Shares	N/A
Revised Initial Shares	N/A
Initial Price	N/A
Revised Price	N/A
Final Price	N/A
Final Ticker	N/A